Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity

Overview of attention for article published in OncoImmunology, June 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity

Article in Nature Communications (November 2021)

CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity

Article in Leukemia (May 2021)

Chapter 14 Checkpoint inhibition in the fight against cancer: NK cells have some to say in it

Book chapter (January 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.